Alan F. Schatzberg, M.D.
Kenneth T. Norris Jr. Professor and Chair, Department of
Psychiatry and Behavioral Sciences, Stanford University
School of Medicine, Stanford, California
Charles B. Nemeroff, M.D., Ph.D.
Reunette W. Harris Professor, Department of Psychiatry and
Behavioral Sciences, Emory University, Atlanta, Georgia
Elias Aboujaoude, M.D.
Assistant Clinical Professor, Department of Psychiatry and
Behavioral Sciences, Stanford University School of Medicine,
Stanford, California
W. Stewart Agras, M.D.
Professor of Psychiatry, Department of Psychiatry and Behavioral
Sciences, Stanford University School of Medicine,
Stanford, California
Jonathan M. Amiel, M.D.
Resident in Psychiatry, Columbia University College of
Physicians and Surgeons and the New York State Psychiatric
Institute, New York, New York
Josephine Astrid Archer, B.Sc.
Research Student, Centre for Psychiatry, Queen Mary University
of London, Barts and The London School of Medicine
and Dentistry, London, United Kingdom
Steven E. Arnold, M.D.
Professor and Director, Cellular and Molecular Neuropathology
Program, Geriatric Psychiatry Section, Department
of Psychiatry, Penn Memory Center, University of Pennsylvania,
Philadelphia, Pennsylvania
Christos A. Ballas, M.D.
Assistant Professor of Clinical Psychiatry, Department of
Psychiatry, University of Pennsylvania School of Medicine,
Philadelphia, Pennsylvania
Jacob S. Ballon, M.D.
Chief Resident, Department of Psychiatry and Behavioral
Science, Stanford University, Stanford, California
Matthew J. Bair, M.D., M.S.
Assistant Professor of Medicine, Division of General Internal
Medicine and Geriatrics, Department of Medicine, Indiana
University School of Medicine; Research Scientist,
Regenstrief Institute, Inc.; and Center for Implementing Evidence-Based Practice, Richard Roudebush VA Medical
Center, Indianapolis, Indiana
Gregory S. Berns, M.D., Ph.D.
Professor, Department of Psychiatry and Behavioral Sciences,
Emory University School of Medicine, Atlanta, Georgia
Elisabeth B. Binder, M.D., Ph.D.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences and Department of Human Genetics, Emory
University School of Medicine, Atlanta, Georgia; Head,
RG Molecular Genetics of Depression, Max Planck Institute
of Psychiatry, Munich, Germany
Pierre Blier, M.D., Ph.D.
Professor, Departments of Psychiatry and Cellular/Molecular
Medicine, University of Ottawa; Research Director,
Mood Disorders Research Unit, University of Ottawa Institute
of Mental Health Research, Ottawa, Ontario, Canada
David R. Block, M.D.
Staff Psychiatrist, Student Health Services, San Francisco
State University, San Francisco, California
Charles L. Bowden, M.D.
Clinical Professor of Psychiatry and Psychopharmacology,
Department of Psychiatry, University of Texas Health Science
Center at San Antonio, San Antonio, Texas
Catherine Bresee, M.S.
Senior Research Associate, Department of Psychiatry and
Behavioral Neurosciences, Cedars-Sinai Medical Center,
Los Angeles, California
Frank W. Brown, M.D.
Associate Professor of Psychiatry and Behavioral Sciences,
Emory University School of Medicine, and Chief Medical
Officer, Wesley Woods Geriatric Hospital, Emory Health-Care, Atlanta, Georgia
Mary F. Brunette, M.D.
Associate Professor of Psychiatry, Department of Psychiatry,
Dartmouth Psychiatric Research Center, Dartmouth Medical
School, Hanover, New Hampshire
Peter F. Buckley, M.D.
Professor and Chairman, Department of Psychiatry, and Associate
Dean for Leadership Development, Medical College
of Georgia, Augusta, Georgia
Joseph R. Calabrese, M.D.
Director, Center for Bipolar Disorder at Case Western Reserve
University and University Hospitals Case Medical
Center; Professor of Psychiatry, Case Western Reserve University
School of Medicine, Cleveland, Ohio
Carla M. Canuso, M.D.
Senior Director, Clinical Development, Ortho-McNeil Janssen
Scientific Affairs, LLC, Titusville, New Jersey
Linda L. Carpenter, M.D.
Associate Professor, Department of Psychiatry and Human
Behavior, Warren Alpert Medical School of Brown University,
Providence, Rhode Island
Dennis S. Charney, M.D.
Dean and Executive Vice President of Academic Affairs,
Mount Sinai School of Medicine, New York, New York
Anita H. Clayton, M.D.
David C. Wilson Professor, Department of Psychiatry and
Neurobehavioral Sciences, University of Virginia School of
Medicine, Charlottesville, Virginia
Emil F. Coccaro, M.D.
Professor and Chair of Psychiatry, Department of Psychiatry,
University of Chicago, Chicago, Illinois
Kathryn M. Connor, M.D., M.H.S.
Associate Director of Clinical Research, Clinical Neuroscience
and Ophthalmology, Merck & Co, Inc., North
Wales, Pennsylvania (formerly Associate Professor, Department
of Psychiatry and Behavioral Sciences, Duke University
Medical Center, Durham, North Carolina)
Monica Kelly Cowles, M.D., M.S.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences, Winship Cancer Institute (WCI), Emory
School of Medicine, Atlanta, Georgia
Joseph F. Cubells, M.D., Ph.D.
Associate Professor, Department of Psychiatry and Behavioral
Sciences and Department of Human Genetics, Emory
University School of Medicine, Atlanta, Georgia
Charles A. Dackis, M.D.
Associate Professor, Department of Psychiatry, and Medical
Director of Clinical Services, Presbyterian Medical Center,
University of Pennsylvania, Philadelphia, Pennsylvania
Jonathan R. T. Davidson, M.D.
Professor, Department of Psychiatry and Behavioral Sciences,
Duke University Medical Center, Durham, North
Carolina
Albert A. Davis, B.S.
Department of Neurology, Emory University School of
Medicine, Atlanta, Georgia
Karon Dawkins, M.D.
Associate Professor of Psychiatry and Director of General
Psychiatry Residency Training, School of Medicine, University
of North Carolina at Chapel Hill, Chapel Hill,
North Carolina
William C. Dement, M.D., Ph.D.
Lowell W. and Josephine Q. Berry Professor, Department of
Psychiatry and Behavioral Sciences, Stanford University
School of Medicine, Stanford, California; Director, Stanford
Sleep Disorders Center, Palo Alto, California
D. P. Devanand, M.D.
Professor of Clinical Psychiatry and Neurology, College of
Physicians and Surgeons, Columbia University; Co-Director,
Memory Disorders Center, New York State Psychiatric
Institute, New York, New York
C. Lindsay DeVane, Pharm.D.
Professor of Psychiatry and Behavioral Sciences and Director,
Laboratory of Drug Disposition and Pharmacogenetics,
Department of Psychiatry, Medical University of South
Carolina, Charleston, South Carolina
David F. Dinges, Ph.D.
Professor of Psychology in Psychiatry, Chief, Division of
Sleep and Chronobiology, Director, Unit for Experimental
Psychiatry, Department of Psychiatry, University of Pennsylvania
School of Medicine, Philadelphia, Pennsylvania
Barbara D'Orio, M.D., M.P.A.
Associate Professor, Department of Psychiatry and Behavioral
Sciences, Emory University School of Medicine, Atlanta,
Georgia
David L. Dunner, M.D.
Professor, Department of Psychiatry and Behavioral Sciences,
and Director, Center for Anxiety and Depression,
University of Washington, Seattle, Washington
Clifford J. Ehmke, M.D.
Department of Psychiatry and Behavioral Sciences, Emory
University School of Medicine, Atlanta, Georgia
Dwight L. Evans, M.D.
Ruth Meltzer Professor and Chairman, Professor of Psychiatry,
Medicine, and Neuroscience, Department of Psychiatry,
University of Pennsylvania School of Medicine, Philadelphia,
Pennsylvania
Elise M. Fallucco, M.D.
Clinical Fellow—Child and Adolescent Psychiatry, Washington
University School of Medicine, St. Louis, Missouri
Susana V. Fernandez, B.A.
Research Interviewer, Department of Psychiatry, Emory
University School of Medicine, Atlanta, Georgia
Adriana E. Foster, M.D.
Assistant Professor, Department of Psychiatry and Health
Behavior, Medical College of Georgia, Augusta, Georgia
Marlene P. Freeman, M.D.
Center for Women's Mental Health, Perinatal and Reproductive
Psychiatry Clinical Research Program, Massachusetts
General Hospital, Boston, Massachusetts; Harvard
Medical School
Mark A. Frye, M.D.
Consultant, Department of Psychiatry and Psychology, Director,
Mayo Mood Clinic and Research Program, Mayo
Clinic, Rochester, Minnesota
Keming Gao, M.D., Ph.D.
Director, Mood and Anxiety Clinic, Assistant Professor of
Psychiatry, University Hospitals Case Medical Center, Case
Western Reserve University School of Medicine, Cleveland,
Ohio
Amir Garakani, M.D.
Visiting Associate, Mount Sinai School of Medicine, New
York, New York
Steven J. Garlow, M.D., Ph.D.
Director of Adult Mental Health Services and Emergency
Psychiatry, Emory University Hospital; Assistant Professor,
Department of Psychiatry and Behavioral Sciences, Emory
University School of Medicine, Atlanta, Georgia
Alan J. Gelenberg, M.D.
President and CEO, Healthcare Technology Systems Inc.,
Madison, Wisconsin; Clinical Professor of Psychiatry, University
of Wisconsin, Madison, Wisconsin; Professor Emeritus
of Psychiatry, University of Arizona College of
Medicine, Tucson, Arizona
Charles F. Gillespie, M.D., Ph.D.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences, Emory University School of Medicine, Atlanta,
Georgia
Elizabeth H. Gillespie, D.O.
Child and Adolescent Psychiatry Fellow, Department of
Psychiatry and Neurobehavioral Sciences, University of
Virginia, Charlottesville, Virginia
Donald C. Goff, M.D.
Director, Schizophrenia Program, Massachusetts General
Hospital; Associate Professor of Psychiatry, Harvard Medical
School, Boston, Massachusetts
Robert N. Golden, M.D.
Professor of Psychiatry and Dean, School of Medicine and
Public Health, University of Wisconsin–Madison, Madison,
Wisconsin
Jennifer Gotto, M.D.
Chief, Department of Psychiatry, Division of Supportive
Care Medicine, City of Hope Cancer Center, Duarte, California
Todd D. Gould, M.D.
Assistant Professor, Department of Psychiatry, School of
Medicine, University of Maryland, Baltimore, Maryland
Anthony A. Grace, Ph.D.
Professor of Neuroscience, Psychiatry, and Psychology, Department
of Neuroscience, University of Pittsburgh School
of Medicine, Pittsburgh, Pennsylvania
Alan I. Green, M.D.
Raymond Sobel Professor of Psychiatry and Chairman, Department
of Psychiatry, Dartmouth Medical School, Hanover,
New Hampshire
Raquel E. Gur, M.D., Ph.D.
Professor and Director, Schizophrenia Research Center,
Neuropsychiatry Section, Department of Psychiatry, University
of Pennsylvania, Philadelphia, Pennsylvania
Ebrahim Haroon, M.D.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences, Emory University School of Medicine, Atlanta,
Georgia
Christine M. Heim, Ph.D.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences, Emory University School of Medicine, Atlanta,
Georgia
Eric Hollander, M.D.
Professor of Psychiatry and Director of Clinical Psychopharmacology,
Department of Psychiatry, Mount Sinai School of
Medicine, New York, New York
Florian Holsboer, M.D., Ph.D.
Director and Professor, Max Planck Institute of Psychiatry,
Munich, Germany
Jinger G. Hoop, M.D., M.F.A.
Assistant Professor, Department of Psychiatry and Behavioral
Medicine, Medical College of Wisconsin, Milwaukee,
Wisconsin
Sandra Juric, B.A.
Research Interviewer, Department of Psychiatry, Emory
University School of Medicine, Atlanta, Georgia
Ned H. Kalin, M.D.
Hedberg Professor and Chair, Department of Psychiatry;
and Director, HealthEmotions Research Institute, University
of Wisconsin School of Medicine and Public Health,
Madison, Wisconsin
Walter H. Kaye, M.D.
Professor of Psychiatry and Director of the Eating Disorder
Program, Department of Psychiatry, University of California
at San Diego, La Jolla, California
Paul E. Keck Jr., M.D.
President–CEO, Lindner Center of HOPE, Mason, Ohio;
Lindner Professor of Psychiatry and Neuroscience and Executive
Vice Chair, University of Cincinnati College of Medicine,
Cincinnati, Ohio
David E. Kemp, M.D.
Director, Mood and Metabolic Clinic, Assistant Professor of
Psychiatry, University Hospitals Case Medical Center, Case
Western Reserve University School of Medicine, Cleveland,
Ohio
Ashley P. Kennedy, B.S.
Department of Psychiatry and Behavioral Sciences, Emory
University School of Medicine, Atlanta, Georgia
Terence A. Ketter, M.D.
Professor of Psychiatry and Behavioral Sciences and Chief,
Bipolar Disorders Clinic, Stanford University School of
Medicine, Stanford, California
Clinton D. Kilts, Ph.D.
Paul Janssen Professor and Vice Chair for Research, Department
of Psychiatry and Behavioral Sciences, Emory University
School of Medicine, Atlanta, Georgia
Lorrin M. Koran, M.D.
Professor, Department of Psychiatry and Behavioral Sciences,
Stanford University School of Medicine, Stanford,
California
Ania Korszun, Ph.D., M.D., M.R.C.Psych.
Professor of Psychiatry, Centre for Psychiatry, Queen Mary
University of London, Barts and The London School of
Medicine and Dentistry, London, United Kingdom
Helena C. Kraemer, Ph.D.
Professor of Biostatistics in Psychiatry, Emerita, Department
of Psychiatry and Behavioral Sciences, Stanford University
School of Medicine, Stanford, California
Erin E. Krebs, M.D., M.P.H.
Assistant Professor of Medicine, Division of General Internal
Medicine and Geriatrics, Department of Medicine, Indiana
University School of Medicine; Research Scientist,
Regenstrief Institute, Inc.; and Center for Implementing Evidence-Based Practice, Richard Roudebush VA Medical
Center, Indianapolis, Indiana
K. Ranga Rama Krishnan, M.D.
Professor and Chairman, Department of Psychiatry and Behavioral
Sciences, Duke University Medical Center,
Durham, North Carolina; Dean, Duke–NUS Graduate
Medical School Singapore
Kurt Kroenke, M.D.
Professor of Medicine, Division of General Internal Medicine
and Geriatrics, Department of Medicine, Indiana University
School of Medicine; Research Scientist, Regenstrief
Institute, Inc.; and Center for Implementing Evidence-Based Practice, Richard Roudebush VA Medical Center, Indianapolis,
Indiana
David J. Kupfer, M.D.
Thomas Detre Professor and Chair, Department of Psychiatry,
and Professor of Neuroscience, University of Pittsburgh
School of Medicine, Pittsburgh, Pennsylvania
James J. Lah, M.D., Ph.D.
Associate Professor, Department of Neurology, Emory University
School of Medicine, Atlanta, Georgia
Joseph B. Layde, M.D., J.D.
Professor, Department of Psychiatry and Behavioral Medicine,
Medical College of Wisconsin, Milwaukee, Wisconsin
Royce Lee, M.D.
Assistant Professor of Psychiatry, Department of Psychiatry,
University of Chicago, Chicago, Illinois
Allan I. Levey, M.D., Ph.D.
Professor and Chair, Department of Neurology, Emory University
School of Medicine, Atlanta, Georgia
David A. Lewis, M.D.
UPMC Professor, Translational Neuroscience Program, Departments
of Psychiatry and Neuroscience; Director, Center
for the Neuroscience of Mental Disorders; and Associate Director
for Basic Research, Western Psychiatric Institute and
Clinic, University of Pittsburgh School of Medicine, Pittsburgh,
Pennsylvania
Jeffrey A. Lieberman, M.D.
Chairman, Department of Psychiatry, College of Physicians
and Surgeons, Columbia University; Director, New York
State Psychiatric Institute; Director, Lieber Center for
Schizophrenia Research; Psychiatrist-in-Chief, New York
Presbyterian Hospital and Columbia University Medical
Center, New York, New York
David M. Lyons, Ph.D.
Associate Professor, Department of Psychiatry and Behavioral
Sciences, Stanford University School of Medicine,
Stanford, California
Robert C. Malenka, M.D., Ph.D.
Pritzker Professor of Psychiatry and Behavioral Sciences,
Stanford Brain Research Institute, Stanford University
School of Medicine, Stanford, California
Husseini K. Manji, M.D.
Vice President, CNS and Pain, Johnson & Johnson Pharmaceutical
Research & Development, Titusville, New Jersey
Stephen R. Marder, M.D.
Professor and Director, Section on Psychosis, Semel Institute
of Neuroscience and Human Behavior, University of
California at Los Angeles; Director, Desert Pacific Mental
Illness Research, Education, and Clinical Center, West Los
Angeles Veterans Administration Medical Center, Los Angeles,
California
Sanjay J. Mathew, M.D.
Director, Mood and Anxiety Disorders Program, and Associate
Professor of Psychiatry, Mount Sinai School of Medicine,
New York, New York
Helen S. Mayberg, M.D.
Professor, Department of Psychiatry and Behavioral Sciences,
and Professor, Department of Neurology, Emory University
School of Medicine, Atlanta, Georgia
W. Vaughn McCall, M.D., M.S.
Professor and Chair, Department of Psychiatry and Behavioral
Medicine, Wake Forest University School of Medicine;
Medical Director, Sleep Center, Wake Forest
University Baptist Medical Center, Winston-Salem, North
Carolina
William M. McDonald, M.D.
Professor of Psychiatry and J.B. Fuqua Chair for Late-Life
Depression, Emory University School of Medicine; Chief,
Division of Geriatric Psychiatry, Director, Fuqua Center for
Late-Life Depression, Atlanta, Georgia
Susan L. McElroy, M.D.
Chief Research Officer, Lindner Center of HOPE, Mason,
Ohio; Professor of Psychiatry and Neuroscience, University
of Cincinnati College of Medicine, Cincinnati, Ohio
Thomas W. Meeks, M.D.
Assistant Professor of Psychiatry, Division of Geriatric Psychiatry,
University of California–San Diego, VA San Diego
Healthcare System, San Diego, California
Darlene S. Melchitzky, M.S.
Research Principal, Department of Psychiatry, University of
Pittsburgh School of Medicine, Pittsburgh, Pennsylvania;
Laboratory Director, Department of Biology, Mercyhurst
College, Erie, Pennsylvania
Emmanuel Mignot, M.D., Ph.D.
Howard Hughes Medical Institute Investigator; Professor of
Psychiatry and Behavioral Sciences, Stanford University
School of Medicine, Stanford, California; Director, Center
for Narcolepsy, Stanford Sleep Research Center, Palo Alto,
California
Andrew H. Miller, M.D.
Professor, Department of Psychiatry and Behavioral Sciences,
Winship Cancer Institute (WCI), Emory School of Medicine,
Atlanta, Georgia
Kazuo Mishima, M.D., Ph.D.
Director, National Institute of Mental Health, National
Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan
Katherine Marshall Moore, M.D.
Consultant, Department of Psychiatry and Psychology, Director,
Mayo Clinic Anxiety Disorders Clinic, Mayo Clinic,
Rochester, Minnesota
David J. Muzina, M.D.
Director, Center for Mood Disorders Treatment and Research,
Associate Professor of Medicine, Cleveland Clinic
Neurological Institute, Cleveland, Ohio
Henry A. Nasrallah, M.D.
Professor of Psychiatry and Neuroscience, Department of
Psychiatry, University of Cincinnati College of Medicine,
Cincinnati, Ohio
J. Craig Nelson, M.D.
Professor of Psychiatry, Leon J. Epstein, M.D., Chair in Geriatric
Psychiatry, Director of Geriatric Psychiatry, University
of California–San Francisco
Charles B. Nemeroff, M.D., Ph.D.
Reunette W. Harris Professor, Department of Psychiatry and
Behavioral Sciences, Emory University, Atlanta, Georgia
Alexander Neumeister, M.D.
Associate Professor of Psychiatry and Director of the Molecular
Imaging Program of the Clinical Neurosciences Division,
Yale University School of Medicine, West Haven,
Connecticut
John W. Newcomer, M.D.
Gregory B. Couch Professor of Psychiatry, Psychology and
Medicine and Medical Director, Center for Clinical Studies,
Washington University School of Medicine, St. Louis, Missouri
D. Jeffrey Newport, M.D.
Associate Professor, Department of Psychiatry, Emory University
School of Medicine, Atlanta, Georgia
Linda Nicholas, M.D.
Professor of Psychiatry, School of Medicine, University of
North Carolina at Chapel Hill, Chapel Hill, North Carolina
Seiji Nishino, M.D., Ph.D.
Professor of Psychiatry and Behavioral Sciences, Stanford
University School of Medicine, Stanford, California; Director,
Sleep and Circadian Neurobiology Laboratory, Stanford
Sleep Research Center, Palo Alto, California
Sandhaya Norris, M.D.
Physician, Mood Disorders Research Unit, University of Ottawa
Institute of Mental Health Research, Ottawa, Ontario,
Canada
Charles P. O'Brien, M.D., Ph.D.
Kenneth Appel Professor, Department of Psychiatry, University
of Pennsylvania, Philadelphia, Pennsylvania
Giuseppe Pagnoni, Ph.D.
Dip. Scienze Biomediche, Sezione Fisiologia, Università di
Modena e Reggio Emilia, Modeno, Italy
Daniel S. Pine, M.D.
Chief of Developmental Studies, Mood and Anxiety Disorders
Program, National Institute of Mental Health, Bethesda,
Maryland
Steven R. Pliszka, M.D.
Professor and Vice Chair, Chief, Division of Child and Adolescent
Psychiatry, Department of Psychiatry, The University
of Texas Health Science Center at San Antonio
Bruce G. Pollock, M.D., Ph.D.
Professor and Head, Division of Geriatric Psychiatry, University
of Toronto Faculty of Medicine; Sandra A. Rotman
Chair in Neuropsychiatry, Rotman Research Institute, Baycrest;
Vice President of Research, Centre for Addiction and
Mental Health, Toronto, Ontario, Canada
Robert M. Post, M.D.
Clinical Professor of Psychiatry, George Washington University,
Washington, DC, and Penn State College of Medicine,
Hershey, Pennsylvania; Head, Bipolar Collaborative
Network, Bethesda, Maryland
David C. Purselle, M.D., M.S.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences, Emory University School of Medicine; Director
of Acute Mental Health Services, Veterans Affairs
Medical Center, Atlanta, Georgia
Charles L. Raison, M.D.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences, Winship Cancer Institute (WCI), Emory
School of Medicine, Atlanta, Georgia
B. Ashok Raj, M.D.
Physician Researcher, University of South Florida College
of Medicine, Tampa, Florida
Mark Hyman Rapaport, M.D.
Chairman, Department of Psychiatry and Neurosciences,
Cedars-Sinai Medical Center; Professor of Psychiatry and
Biobehaviorial Sciences and Polier Family Endowed Chair
for Schizophrenia and Related Disorders, David Geffen
School of Medicine, University of California–Los Angeles
Mark M. Rasenick, Ph.D.
Professor of Physiology and Biophysics and Psychiatry, Departments
of Physiology and Biophysics and Psychiatry,
University of Illinois at Chicago, Chicago, Illinois
Martin Reite, M.D.
Diplomate, American Board of Sleep Medicine; Diplomate,
American Board of Psychiatry and Neurology; Clinical Professor,
Department of Psychiatry and Medical Director,
Neuromagnetic Imaging Lab, University of Colorado
School of Medicine, Denver, Colorado
Karl Rickels, M.D.
Stuart and Emily B.H. Mudd Professor of Behavior and Reproduction
in Psychiatry, Department of Psychiatry, University
of Pennsylvania, Philadelphia, Pennsylvania
Laura Weiss Roberts, M.D., M.A.
Charles E. Kubly Professor and Chairman, Department of
Psychiatry and Behavioral Medicine, Medical College of
Wisconsin, Milwaukee, Wisconsin
Donald S. Robinson, M.D.
Consultant, Worldwide Drug Development, Shelburne,
Vermont
Steven P. Roose, M.D.
Professor of Clinical Psychiatry, College of Physicians and
Surgeons, Columbia University; Co-Director, Neuropsychiatric
Research Clinic, New York State Psychiatric Institute,
New York, New York
Patrick H. Roseboom, Ph.D.
Associate Scientist in Psychiatry and Lecturer in Pharmacology,
University of Wisconsin School of Medicine and
Public Health, Madison, Wisconsin
Jerrold F. Rosenbaum, M.D.
Chief of Psychiatry, Massachusetts General Hospital; Stanley
Cobb Professor of Psychiatry, Harvard Medical School,
Boston, Massachusetts
J. Amiel Rosenkranz, Ph.D.
Assistant Professor, Department of Cellular and Molecular
Pharmacology, Rosalind Franklin University of Medicine
and Science, North Chicago, Illinois
Carl Salzman, M.D.
Professor of Psychiatry, Harvard Medical School, Beth Israel
Deaconess Medical Center, Boston, Massachusetts
Alan F. Schatzberg, M.D.
Kenneth T. Norris Jr. Professor and Chair, Department of
Psychiatry and Behavioral Sciences, Stanford University
School of Medicine, Stanford, California
S. Charles Schulz, M.D.
Professor and Head, Department of Psychiatry, University of
Minnesota School of Medicine, Riverside, Minneapolis, Minnesota
Zafar A. Sharif, M.D.
Associate Clinical Professor of Psychiatry, Department of
Psychiatry, College of Physicians and Surgeons, Columbia
University, New York, New York
David V. Sheehan, M.D., M.B.A.
Distinguished University Health Professor, University of
South Florida College of Medicine, Tampa, Florida
Daphne Simeon, M.D.
Associate Professor, Department of Psychiatry, Mount Sinai
School of Medicine, New York, New York
George M. Simpson, M.D.
Interim Chair and Professor of Research Psychiatry, Department
of Psychiatry and the Behavioral Sciences, USC Keck
School of Medicine, Los Angeles, California
Diane M. Sloan, Pharm.D.
Senior Medical Director, Advogent, Wayne, New Jersey
Joseph K. Stanilla, M.D.
Assistant Professor of Psychiatry, Jefferson Medical College
of Thomas Jefferson University, Philadelphia, Pennsylvania
Zachary N. Stowe, M.D.
Professor, Department of Psychiatry and Department of Gynecology/Obstetrics, Emory University School of Medicine,
Atlanta, Georgia
Michael A. Strober, Ph.D.
Franklin Mint Chair in Eating Disorders and Professor of
Psychiatry, Semel Institute for Neuroscience and Human
Behavior and Stewart and Lynda Resnick Neuropsychiatric
Hospital, David Geffen School of Medicine, University of
California at Los Angeles, Los Angeles, California
Steven T. Szabo, Ph.D.
Mood and Anxiety Disorders Program, Laboratory of Molecular
Pathophysiology, National Institute of Mental Health,
National Institutes of Health, Bethesda, Maryland
Rajiv Tandon, M.D.
Chief of Psychiatry, State of Florida Program of Mental
Health, Department of Children and Families, Tallahassee,
Florida
Pierre N. Tariot, M.D.
Director, Memory Disorders Center, Banner Alzheimer's Institute;
and Research Professor of Psychiatry, University of
Arizona College of Medicine, Phoenix, Arizona
Michael E. Thase, M.D.
Professor, Department of Psychiatry, University of Pennsylvania
School of Medicine, Philadelphia Veterans Affairs
Medical Center, Philadelphia, Pennsylvania; and Adjunct
Professor, University of Pittsburgh Medical Center, Pittsburgh,
Pennsylvania
Gary D. Tollefson, M.D., Ph.D.
CEO/President, Orexigen Therapeutics, La Jolla, California
Karen Dineen Wagner, M.D., Ph.D.
Marie B. Gale Centennial Professor and Vice-Chair, Department
of Psychiatry and Behavioral Sciences; Director,
Division of Child and Adolescent Psychiatry, The University
of Texas Medical Branch, Galveston, Texas
Po W. Wang, M.D.
Clinical Associate Professor, Department of Psychiatry and
Behavioral Sciences, Stanford University School of Medicine,
Stanford, California
Margaret B. Weigel, M.D.
Assistant Professor, Department of Psychiatry and Behavioral
Sciences, Emory University School of Medicine; Staff
Physician, Veterans Affairs Medical Center, Atlanta, Georgia
Anthony R. West, Ph.D.
Associate Professor, Department of Neuroscience, The Chicago
Medical School of Rosalind Franklin University of
Medicine and Science, North Chicago, Illinois
Christopher B. Wiegand, M.D.
Clinical Assistant Professor of Psychiatry, Department of
Psychiatry, University of Arizona College of Medicine, Tucson,
Arizona
Donna A. Wirshing, M.D.
Associate Professor, Semel Institute of Neuroscience and
Human Behavior, David Geffen School of Medicine, University
of California at Los Angeles; West Los Angeles Veterans
Administration Medical Center, Los Angeles,
California
Joanne D. Wojcik, P.M.H.C.N.S.–B.C.
Instructor in Psychiatry and Associate Director, Commonwealth
Research Center and the Massachusetts Mental
Health Center, Department of Psychiatry, Harvard Medical
School, Boston, Massachusetts
Tsung-Ung W. Woo, M.D., Ph.D.
Assistant Professor of Psychiatry, Beth Israel Deaconess
Medical Center and McLean Hospital, Department of Psychiatry,
Harvard Medical School, Boston, Massachusetts
Frank D. Yocca, Ph.D.
Vice President and Head, CNS and Pain Discovery, AstraZeneca Pharmaceuticals Co., Wilmington, Delaware
Kimberly A. Yonkers, M.D.
Associate Professor, Departments of Psychiatry, Obstetrics,
Gynecology and Reproductive Sciences, Yale School of
Medicine, New Haven, Connecticut
Elizabeth Ann Young, M.D.
Professor of Psychiatry, Department of Psychiatry, University
of Michigan, Ann Arbor, Michigan
Jiang-Zhou Yu, M.D., Ph.D.
Research Assistant Professor, Departments of Physiology
and Biophysics and Psychiatry, University of Illinois at Chicago,
Chicago, Illinois
Janos Zahajszky, M.D.
Medical Director of Outpatient Mental Health, California
Pacific Medical Center, San Francisco, California
Wei Zhang, M.D., Ph.D.
Director, Anxiety and Traumatic Stress Program, Department
of Psychiatry and Behavioral Sciences, Duke University
Medical Center, Durham, North Carolina
Charles F. Zorumski, M.D.
Samuel B. Guze Professor of Psychiatry, Department of Psychiatry,
Washington University School of Medicine, St.
Louis, Missouri
The following contributors to this textbook have indicated a financial interest
in or other affiliation with a commercial supporter, manufacturer
of a commercial product, and/or provider of a commercial service as
listed below:
Elias Aboujaoude, M.D. Research Support: Eli Lilly and Forest
Laboratories (as co-investigator in clinical trials).
Matthew J. Bair, M.D., M.S. Advisory Board: Abbott, and
Ortho-McNeil-PriCare Division.
Christos A. Ballas, M.D. Speakers Bureau: AstraZeneca, Cephalon,
and Pfizer; Consultant: AstraZeneca, GlaxoSmithKline,
Pfizer, and Wyeth.
Pierre Blier, M.D., Ph.D. Grant/Grant/Research Support: Eli
Lilly, Forest Laboratories, Lundbeck, Sepracor, and Wyeth-Ayerst; Consultant/Advisory Board: Eli Lilly, Forest Laboratories,
Lundbeck, Sepracor, and Wyeth-Ayerst; Speakers Bureau:
Eli Lilly, Forest Laboratories, Lundbeck, Sepracor, and Wyeth-Ayerst.
Elisabeth B. Binder, M.D., Ph.D. Grant/Research Support: Doris
Duke Foundation, GlaxoSmithKline, NARSAD, National
Institutes of Health, and Pfizer; Speaker's Honorarium: AstraZeneca.
Charles L. Bowden, M.D. Grant/Research Support: Abbott Laboratories,
Bristol-Myers Squibb, Elan Pharmaceuticals,
GlaxoSmithKline, Janssen, Lilly Research, National Institute
of Mental Health, Parke Davis, R.W. Johnson Pharmaceutical
Institute, SmithKlineBeecham, and Stanley Medical Research
Foundation, Consultant: Abbott Laboratories, GlaxoSmithKline, Janssen, Lilly Research, Sanofi-Synthelabo, and
UCB Pharma; Speakers Bureau: Abbott Laboratories, AstraZeneca, GlaxoSmithKline, Janssen, Lilly Research, and Pfizer.
Peter F. Buckley, M.D. Grant/Research Support: AstraZeneca,
National Institute of Mental Health, Janssen Pharmaceutica,
Pfizer, Solvay, and Wyeth; Consultant (Honorarium/Expenses):
Janssen Pharmaceutica and National Institute of Mental
Health.
Joseph R. Calabrese, M.D. Grant/Research Support: Abbott, AstraZeneca,
Cleveland Foundation, GlaxoSmithKline, Janssen,
Lilly, NARSAD, Repligen, and Stanley Medical Research
Institute; Federal Funding: Department of Defense,
Health Resources Services Administration, and National Institute
of Mental Health; Advisory Board: Abbott, AstraZeneca,
Bristol-Myers Squibb, France Foundation, GlaxoSmithKline, Janssen, Johnson & Johnson Pharmaceutical Research
& Development, and Solvay/Wyeth; CME Activities: AstraZeneca, Bristol-Myers Squibb, France Foundation, GlaxoSmithKline, Janssen, Johnson & Johnson, and Solvay/Wyeth.
Carla M. Canuso, M.D. Employed by: Ortho-McNeil Janssen
Scientific Affairs; Stock: Johnson & Johnson.
Linda L. Carpenter, M.D. Grant/Research Support: NARSAD,
National Institute of Mental Health, Pfizer, Sepracor, and
UCB Pharma; Consultant/Advisory Board: Abbott, Bristol-Myers Squibb, Cyberonics, Medtronic, Novartis, Pfizer,
Sepracor, and Wyeth; Honoraria for CME: APA, Cyberonics,
and Wyeth; Speakers Bureau: AstraZeneca, Cyberonics, and
Pfizer; Travel Support: Neuronetics.
Anita H. Clayton, M.D. Grant/Research Support: BioSame Pharmaceuticals,
Boehringer-Ingelheim, Bristol-Myers Squibb, Eli
Lilly, Forest Pharmaceuticals, GlaxoSmithKline, Neuronetics,
Pfizer, Sanofi-Aventis, and Wyeth; Consultant/Advisory
Board: Boehringer-Ingelheim, Bristol-Myers Squibb, Eli Lilly,
Fabre-Kramer Pharmaceuticals, GlaxoSmithKline, Novartis
Pharmaceuticals, Pfizer, Vela Pharmaceuticals, and Wyeth;
Speakers Bureau/Honoraria: Eli Lilly, GlaxoSmithKline, Pfizer,
and Wyeth.
Emil F. Coccaro, M.D. Consultant: Azevan Pharmaceuticals.
Kathryn M. Connor, M.D., M.H.S. Employed by: Merck & Co,
Inc.
Joseph F. Cubells, M.D., Ph.D. Grant/Research Support: NARSAD,
National Institute on Drug Abuse, National Institute of
Mental Health, and The Robert W. Woodruff Fund of Emory
University.
D.P. Devanand, M.D. Research Support: Eli Lilly, Forest Labs,
and GlaxoSmithKline, and Wyeth.
C. Lindsay DeVane, Pharm.D. Grant/Research Support: National
Institute on Drug Abuse and National Institute of Mental
Health; Consultant: Bristol-Myers Squibb, CME, Eli Lilly,
GlaxoSmithKline, Janssen Pharmaceuticals, Medscape, Novadel
Pharma, Primedia Healthcare, and Theracos.
David F. Dinges, Ph.D. Grant/Research Support: Cephalon, and
Merck; Consultant/Scientific Advisor: Arena Pharmaceuticals,
Cephalon, GlaxoSmithKline, ILSI North America, Mars
Masterfoods, Merck, Neurogen, Novartis, Pfizer, Procter &
Gamble, and Takeda.
Barbara D'Orio, M.D., M.P.A. Grant/Research Support: American
Foundation for Suicide Prevention, Emory Medical Care
Foundation, and National Institute of Mental Health.
David L. Dunner, M.D. Grant/Research Support: Bristol-Myers
Squibb, Cyberonics, Eli Lilly, Forest, GlaxoSmithKline, Janssen,
Pfizer, and Wyeth; Consultant/Advisory Board: Bristol-Myers Squibb, Cypress, Corcept, Eli Lilly, Forest, GlaxoSmithKline, Janssen, Novartis, Otsuka, Pfizer, Roche Diagnostics,
Shire, Somerset, and Wyeth; Speakers Bureau: Bristol-Myers Squibb, Eli Lilly, Forest, GlaxoSmithKline, Organon,
Pfizer, and Wyeth.
Susana V. Fernandez, B.A. Research Support: National Institutes
of Health.
Marlene P. Freeman, M.D. Research Support: Forest, Institute for
Mental Health Research (Arizona), Lilly, National Institute
of Mental Health, Pronova Biocare (research materials), Reliant
(for investigator-initiated trials), and U.S. Food and
Drug Administration.
Mark A. Frye, M.D. Research Support: Abbott Laboratories,
Cephalon, GlaxoSmithKline, Janssen Pharmaceutica, and
Pfizer; Consultant: Abbott Laboratories, Bristol-Myers Squibb,
Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutica, Organon,
and Otsuka Pharmaceuticals; CME Supported Activities: AstraZeneca,
Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline,
Organon, and Otsuka Pharmaceuticals; Travel Support: Bristol-Myers Squibb, Cephalon, Organon, and Otsuka Pharmaceuticals.
Keming Gao, M.D., Ph.D. Grant/Research Support: Abbott, AstraZeneca,
GlaxoSmithKline, and NARSAD; Speakers Bureau:
AstraZeneca.
Steven J. Garlow, M.D., Ph.D. Grant/Research Support: Janssen
Pharmaceutical, NARSAD, and National Institute of Mental
Health; Consultant: Eli Lilly, and Solvay Pharmaceuticals; Scientific
Advisor/Grant Review: American Foundation for Suicide
Prevention, Constella Group, and Oak Ridge Associated
Universities; Honoraria: CME; Speakers Bureau: Eli Lilly, and
Pfizer.
Alan J. Gelenberg, M.D. Research Support: Novartis Pharmaceuticals;
Consultant: AstraZeneca, Best Practice, Cyberonics, Eli
Lilly, Forest, GlaxoSmithKline, Novartis, Pfizer, and Wyeth;
Stock Options: Vela Pharmaceuticals.
Charles F. Gillespie, M.D., Ph.D. Grant/Research Support:
APIRE/Wyeth, National Institute on Drug Abuse, and NARSAD;
Review Board: CME outfitters.
Donald C. Goff, M.D. Research Support: Bristol-Myers Squibb,
Cephalon, Dainippon Sumitomo, Eli Lilly, Janssen Pharmaceuticals,
Letters and Science, Organon, Pfizer, Primedia, Proteus,
SG Cowen, Solvay/Wyeth, Vanda Pharmaceuticals,
Verusmed, Vista Research, Xenoport, and Xytis.
Anthony A. Grace, Ph.D. Grant/Research Support: Lundbeck
Pharmaceuticals; Consultant: Johnson & Johnson, and Taisho
Pharmaceuticals.
Alan I. Green, M.D. Research Support: AstraZeneca, Bristol-Myers,
Cyberonics, Forest, Janssen, Lilly, and Novartis; Consultant/Advisory Board: AstraZeneca, Cyberonics, Janssen, and
Lilly; Stock: Johnson & Johnson, and Meylau.
Raquel E. Gur, M.D., Ph.D. Investigator: AstraZeneca.
Eric Hollander, M.D. Research Support: Abbott, FDA (Oprah
products), National Institute on Drug Abuse, National Institute
of Mental Health, National Institute of Neurological Disorders
and Stroke, Ortho-McNeil, and Pfizer; Consultant: Abbott,
and Neuropharm.
Florian Holsboer, M.D., Ph.D. Shareholder: Amectis Pharmaceuticals,
Corcept, and Neurocrine.
Ned H. Kalin, M.D. Research Support/Consultant/Speakers Bureau:
Amgen, AstraZeneca, Bristol-Myers Squibb, Corcept,
CeNeRx Biopharma, Cypress Biosciences, Cyberonics, Forest
Laboratories, GlaxoSmithKline, Janssen Pharmaceutica,
Johnson & Johnson, Lilly, National Institute of Mental
Health, Neurocrine Bio, Neuronetics, Pfizer Pharmaceuticals,
Sanofi-Synthelabo, Stanley Foundation, and Wyeth-Ayerst;
Editor: Nature and Psychoneuroendocrinology (Elsevier); Field
Editor: Neuropsychopharmacology; Stock/Equity Holdings: Corcept,
CeNeRx, and Neurocrine Biosciences; Owner: Promoter
Neurosciences; Patents: U.S. Patent No. 7,071,323—
Kalin NH, Landry CF, Nanda SA, Roseboom PH: Promoter
sequences for corticotropin-releasing factor CRF2alpha and
method of identifying agents that alter the activity of the promoter
sequences; U.S. Patent No. 7,087,385—Kalin NH,
Nanda SA, Roseboom PH: Promoter sequences for urocortin
2 and the use thereof; U.S. Patent No. 7,122,650—Kalin NH,
Nanda SA, and Roseboom PH: Promoter sequences for corticotropin-releasing factor binding protein and use thereof;
U.S. Patent Application No. 10/896544—Bakshi VP, Kalin
NH, Nanda SA, Roseboom PH: Method of reducing CRF receptor
mRNA.
Paul E. Keck Jr., M.D. Research Support: Abbott Laboratories,
AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Eli
Lilly, Janssen Pharmaceutica, National Institute of Mental
Health, National Institute on Drug Abuse, Pfizer, and UCB
Pharma; Consultant: Bristol-Myers Squibb, Eli Lilly, Forest
Laboratories, Organon, and Pfizer; Patents: U.S. Patent No.
6,387,956—Shapira NA, Goldsmith TD, Keck PE Jr. (University
of Cincinnati): Methods of treating obsessive-compulsive
spectrum disorder comprises the step of administering an
effective amount of tramadol to an individual. Filed March
25, 1999; approved May 14, 2002.
David E. Kemp, M.D. Consultant: Abbott, Bristol-Myers
Squibb, and Wyeth.
Terence A. Ketter, M.D. Grant/Research Support: Abbott Laboratories,
AstraZeneca, Bristol-Myers Squibb, Eisai, Elan Pharmaceuticals,
Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutica
Products, Novartis Pharmaceuticals Group, Repligen,
Shire Pharmaceuticals, Solvay Pharmaceuticals, and Wyeth
Pharmaceuticals; Consultant: Abbott Laboratories, AstraZeneca
Pharmaceuticals, Bristol-Myers Squibb, Cephalon, Corcept
Therapeutics, Elan Pharmaceuticals, Eli Lilly, Forest Laboratories,
GlaxoSmithKline, Janssen Pharmaceutica
Products, Jazz Pharmaceuticals, Merck, Novartis Pharmaceuticals,
Pfizer, Repligen, Shire Pharmaceuticals Group, Solvay
Pharmaceuticals, UCB Pharmaceuticals, and Wyeth Pharmaceuticals;
Lecture Honoraria: Abbott Laboratories, AstraZeneca
Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceutica Products, Novartis
Pharmaceuticals, Pfizer, and Shire Pharmaceuticals Group.
Clinton Kilts, Ph.D. Grant/Research Support: National Institutes
of Health; Consultant/Advisory Board: Forest Laboratories, H.
Lundbeck A/S, and Solvay Pharmaceuticals; Patents: U.S. Serial
No. 6,375990 B1, Method and Devices for Transdermal
Delivery of Lithium, Co-holder with C.B. Nemeroff, M.D.,
Ph.D.; Endowed Chair: Paul Janssen Endowed Chair of Neuropsychopharmacology,
Emory University.
Lorrin M. Koran, M.D. Grant Support: Eli Lilly; Consultant: Jazz
Pharmaceuticals.
K. Ranga R. Krishnan, M.D. Consultant: Amgen, Bristol-Myers
Squibb, CeNeRx, Corcept, GlaxoSmithKline, Johnson &
Johnson, Lundbeck, Merck, Organon, Pfizer, Sepracor, Somerset,
and Wyeth.
Kurt Kroenke, M.D. Research Support: Eli Lilly, and Pfizer; Honoraria:
Eli Lilly, and Forest.
David J. Kupfer, M.D. Consultant: Servier Amerique.
Allan I. Levey, M.D., Ph.D. Grant: Acadia Pharmaceuticals.
David A. Lewis, M.D. Research Support: Merck, and Pfizer; Consultant:
BMS, Pfizer, Sepracor, and Wyeth.
Jeffrey A. Lieberman, M.D. Research Support: Acadia, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, Merck, Organon,
and Pfizer; Consultant: Eli Lilly, and Pfizer; Advisory Board:
AstraZeneca, Eli Lilly, GlaxoSmithKline, Lundbeck, Organon,
and Pfizer; Patent: Repligen.
David M. Lyons, Ph.D. Grant/Research Support: Public Health
Service Grants DA16902, MH77884, and MH47573, Pritzker
Neuropsychiatric Disorders Research Consortium which is
supported by the Pritzker Neuropsychiatric Disorders Research
Fund. A shared intellectual property agreement exists
between the Pritzker Neuropsychiatric Disorders Research
Fund and the University of Michigan, the University of California,
and Stanford University to encourage the development
of appropriate findings for research and clinical applications.
Husseini K. Manji, M.D. The work presented in Chapter 1 was
undertaken under the auspices of the National Institute of
Mental Health Intramural Program. Dr. Manji is now at
Johnson & Johnson Pharmaceutical Research & Development.
Stephen R. Marder, M.D. Research Support: Allon, Epix, Merck,
and Novartis; Consultant/Advisory Board: Abbott, Acadia,
Bristol-Myers Squibb, GlaxoSmithKline, Lundbeck, Memory,
Otsuka, Pfizer, and Wyeth.
Sanjay Mathew, M.D. Grant/Research Support: Alexza Pharmaceuticals,
General Clinical Research Center at Mount Sinai
School of Medicine, National Alliance for Research in
Schizophrenia and Depression, National Institute of Mental
Health Career Development Award K23MH0 69656, U19-MH-069056, and Novartis; Compensation: AstraZeneca, Jazz
Pharmaceuticals, and Pfizer; Patent: Inventor on a use patent
of ketamine for the treatment of depression. If ketamine were
shown to be effective in the treatment of depression and received
approval from the U.S. Food and Drug Administration
(FDA) for this indication, Dr. Mathew could benefit financially.
Helen S. Mayberg, M.D. Consultant: Advanced Neuromodel
Systems (ANS); Licensing of IP: ANS.
W. Vaughn McCall, M.D., M.S. Research Support: GlaxoSmithKline, MECTA, Mini Mitter, Neurocrine, Sanofi, Sepracor,
Somaxon, and Wyeth; Speakers Bureau: GlaxoSmithKline,
Sanofi, and Sepracor.
William M. McDonald, M.D. Grant/Research Support: Boehringer
Ingelheim, Fuqua Foundation, Janssen, National Institute
of Mental Health, National Institute of Neurological
Disorders and Stroke, and NeuroNetics; Consultant: Bristol-Myers Squibb, Forest, Janssen, and NeuroNetics; Speakers Bureau:
Bristol-Myers Squibb, Forest, Janssen, and Solvay.
Susan L. McElroy, M.D. Research Support: Abbott Laboratories,
AstraZeneca, Bristol-Myers Squibb, Eisai, Eli Lilly, Forest
Labs, GlaxoSmithKline, Janssen Pharmaceutica, Jazz Pharmaceuticals,
National Institute of Mental Health, OREXIGEN
Therapeutics, Ortho-McNeil Pharmaceutical, Pfizer, Sanofi-Synthelabo, Somaxon Pharmaceuticals, Stanley Medical Research
Institute, and Takeda Pharmaceutical (serves as principal
or co-investigator); Consultant/Advisory Board: Abbott
Laboratories, AstraZeneca, Eli Lilly, GlaxoSmithKline, Janssen
Pharmaceutica, Ortho-McNeil Pharmaceutical, and Wyeth-Ayerst; Patents: U.S. Patent No. 6,323,236B2, Use of
Sulfamate Derivatives for Treating Impulse Control Disorders,
and along with the patent's assignee, University of Cincinnati,
Cincinnati, OH, receives payments from Johnson &
Johnson Pharmaceutical Research & Development, L.L.C.,
which has exclusive rights under the patent.
Andrew H. Miller, M.D. Research Support: Centers for Disease
Control and Prevention, GlaxoSmithKline, Janssen/Johnson
& Johnson, National Institutes of Health, and Schering-Plough; Consultant/Advisory Board: Centocor, and Schering-Plough.
David J. Muzina, M.D. Grant/Research Support: Abbott Labs,
Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Novartis,
Repligen, and Wyeth Pharmaceuticals; Speaking/Advisory
Honoraria: AstraZeneca, GlaxoSmithKline, and Pfizer.
Henry A. Nasrallah, M.D. Grant/Research Support: AstraZeneca,
GlaxoSmithKline, Janssen, Lilly, National Institute of
Mental Health, Pfizer, and Sanofi-Aventis; Consultant: Abbott,
AstraZeneca, Janssen, and Pfizer; Advisory Board: Abbott,
AstraZeneca, Janssen, and Pfizer, Speakers Bureau: Abbott,
AstraZeneca, Janssen, and Pfizer.
J. Craig Nelson, M.D. Advisory Board: Biovail, Bristol-Myers
Squibb, Corcept, Eli Lilly, Forest, GlaxoSmithKline, Novartis,
Orexigen, Organon, and Pfizer; Consultant: Bristol-Myers
Squibb, Corcept, Forest, Merck, and Orexigen.
Charles B. Nemeroff, M.D., Ph.D. Research Support/Board of
Directors/Equity Holdings: American Foundations for Suicide
Prevention (AFSP), CeNeRx, Corcept, George West Mental
Health Foundation, Mt. Cook, National Alliance for Research
on Schizophrenia and Depression (NARSAD), National
Institute of Mental Health, NovaDel Pharmaceuticals,
and Reevax; Scientific Advisory Board: AstraZeneca, Forest
Laboratories, Johnson & Johnson, NARSAD, PharmaNeuroboost,
and Quintiles.
D. Jeffrey Newport, M.D., M.Div. Research Support: Eli Lilly,
GlaxoSmithKline, Janssen, NARSAD, National Institutes of
Health, and Wyeth; Speaker's Honoraria: AstraZeneca, Eli
Lilly, GlaxoSmithKline, and Pfizer.
Linda Nicholas, M.D. Speakers Bureau: AstraZeneca.
Seiji Nishino, M.D., Ph.D. Research Support: Johnson &
Johnson (The Effects of H3 Antagonists on Sleep in Narcoleptic
Mice), Jazz Pharmaceuticals (A Retrospective Chart
Study of the Pediatric Management of Narcolepsy, Narcolepsy
in African Americans, and Narcolepsy in African American
Patients-Hypocretin deficiency without cataplexy).
Charles P. O'Brien, M.D., Ph.D. Consultant/Advisory Board:
Alkermes, Cephalon, Forest, and McNeil.
Steven R. Pliszka, M.D. Research Support: AstraZeneca, Eli
Lilly, and McNeil Pediatrics; Consultant: Ortho-McNeil Scientific,
and Shire; Speakers Bureau: McNeil Pediatrics, and
Shire.
Bruce G. Pollock, M.D., Ph.D. Grant/Research Support: National
Institutes of Health, and Janssen Pharmaceuticals; Advisory
Board: Forest Laboratories; Consultant: Lundbeck, and
Takeda; Speakers Bureau: Forest, and Lundbeck; Faculty: Lundbeck
Institute.
Robert M. Post, M.D. Consultant/Speakers Bureau: Abbott, AstraZeneca,
BMS, and GlaxoSmithKline.
David C. Purselle, M.D., M.S. Speakers Bureau: Pfizer; Faculty:
Lilly.
Charles L. Raison, M.D. Consultant/Advisory Board: Centocor,
Lilly, Schering, and Wyeth; Speakers Bureau: Lilly, and Wyeth.
Mark Hyman Rapaport, M.D. Grant/Research Support: Abbott
Laboratories, AstraZeneca*, Corcept Therapeutics, Cyberonics,
Forest Labs, GlaxoSmithKline, Janssen Pharmaceutica,
NARSAD, NCCAM*, National Institute of Mental Health*,
Novartis, Pfizer, Pharmacia Upjohn, Sanofi-Synthelabo,
Solvay*, Stanley Foundation, UCB Pharma, VA Merit
Award, Volkswagon Stiefhund, and Wyeth; Consultant: Brain
Cells, Cyberonics*, Forest Labs, GlaxoSmithKline, Janssen
Pharmaceutica*, NCCR*, Neurocrine Biosciences, Lilly, National
Institute of Mental Health*, National Institute on
Drug Abuse, Novartis, Pfizer*, Roche, Sanofi Synthelabo,
Schwarz Pharmaceuticals, Solvay*, Sumitomo, and Wyeth*;
Speakers Bureau: Cyberonics, Forest Labs*, GlaxoSmithKline,
Janssen, Lilly, Novartis, Pfizer, Pharmaceutica, and Wyeth*.
*Funding in the past 12 months.
Karl Rickels, M.D. Grant/Research Support: AstraZeneca, Bristol-Myers Squibb, Forest Laboratories, Cephalon, Epix Pharmaceuticals,
Genaissance Pharmaceuticals, Kramer-Fabre,
Merck, National Institute of Mental Health, Pamlab, Pfizer,
Somerset Pharmaceuticals, and Wyeth Lab; Honoraria/Consultant/Advisory Board: Cephalon, DOV Pharmaceuticals, Eli
Lilly, Medicinova, Novartis Pharmaceuticals, Pfizer, PreDix
Pharmaceuticals, and Sanofi-Synthelabo Research.
Donald S. Robinson, M.D. Employed by: Worldwide Drug Development.
Patrick H. Roseboom, Ph.D. Co-Owner: Promoter Neurosciences;
Patents: U.S. Patent No. 7,071,323—Kalin NH,
Landry CF, Nanda SA, Roseboom PH: Promoter sequences for
corticotropin-releasing factor CRF2alpha and method of
identifying agents that alter the activity of the promoter sequences;
U.S. Patent No. 7,087,385—Kalin NH, Nanda SA,
Roseboom PH: Promoter sequences for urocortin 2 and the
use thereof; U.S. Patent No. 7,122,650—Kalin NH, Nanda
SA, and Roseboom PH: Promoter sequences for corticotropin-releasing factor binding protein and use thereof; U.S.
Patent Application No. 10/896544—Bakshi VP, Kalin NH,
Nanda SA, Roseboom PH: Method of reducing CRF receptor
mRNA.
Jerrold F. Rosenbaum, M.D. Consultant: Neuronetics, Organon,
Somaxon Pharm, and Supernus; Advisory Board: Forest, Lilly,
MedAvante, Novartis Pharm, Sanofi Pharm, and Wyeth
Pharm; Speakers Bureau: Boehringer Ingelheim Italia, and Primedia
Health Care (Educational Content Development); Equity
Holdings: Compellis, MedAvante, and Somaxon.
Alan F. Schatzberg, M.D. Consultant: Abbott, BrainCells, CeNeRx,
Corcept (co-founder), Eli Lilly, Forest Labs, Merck, Neuronetics,
Novartis, Pathways Diagnostics, PharmaNeuroBoost, Quintiles, Synosis, and Wyeth; Speakers Bureau:
GlaxoSmithKline; Equity Holdings: Corcept, Forest, Merck,
Neurocrine, and Pfizer; Patents: Named inventor on pharmacogenetic
use patents on prediction of antidepressant response.
S. Charles Schulz, M.D. Grant/Research Support: Abbott, AstraZeneca, Eli Lilly, and MIND Institute; Consultant: AstraZeneca,
Eli Lilly, and Vanda; Honoraria: AstraZeneca, and Eli
Lilly; Speakers Bureau: AstraZeneca, BMS, and Eli Lilly.
Zafar A. Sharif, M.D. Advisory Board: Bristol-Myers Squibb,
and Janssen Pharmaceutica; Speakers Bureau: Bristol-Myers
Squibb, and Janssen Pharmaceutica.
David V. Sheehan, M.D., M.B.A. Grant/Research Support: Abbott
Laboratories, Andote Foundation, AstraZeneca, Avera
Pharmaceuticals, Bristol-Myers Squibb, Burroughs Wellcome,
Eisai, Eli Lilly, Forest Laboratories, GlaxoSmithKline, GlaxoWellcome, International Clinical Research (ICR), Janssen
Pharmaceutica, Jazz Pharmaceuticals, Kali-Duphar, Mead
Johnson, MediciNova, Merck Sharp & Dohme, National Institute
on Drug Abuse, National Institutes of Health, Novartis
Pharmaceuticals Corp., Parke-Davis, Pfizer, Quintiles, Sandoz
Pharmaceuticals, Sanofi-Aventis, Sanofi-Synthelabo Recherche,
SmithKlineBeecham, TAP Pharmaceuticals, United
Bioscience, The Upjohn Company, Warner Chilcott, Wyeth-Ayerst, and Zeneca Pharmaceuticals; Consultant: Abbott Laboratories,
Alexa, Alza Pharmaceuticals, Applied Health Outcomes/XCENDA, AstraZeneca, Avera Pharmaceuticals, Bristol-Myers Squibb, Cephalon, Cortex Pharmaceutical, Cypress
Bioscience, Eisai, Eli Lilly, Forest Laboratories, GlaxoSmithKline, INC Research, Janssen Pharmaceutica, Jazz Pharmaceuticals,
Labopharm, Layton Bioscience, Lilly Research Laboratories,
Lundbeck, Denmark, MediciNova, National
Anxiety Awareness Program, National Anxiety Foundation,
National Depressive & Manic Depressive Association, Organon,
Orion Pharma, Parexel lnternational Corporation,
Pfizer, Pharmacia, Pharmacia & Upjohn, Pierre Fabre, France,
Roche, Sanofi-Aventis, Sanofi-Synthelabo Recherche,
Sepracor, Shire Laboratories, Inc., SmithKlineBeecham,
Solvay Pharmaceuticals, Takeda Pharmaceuticals, Targacept,
The Upjohn Company, Tikvah Therapeutics, Titan Pharmaceuticals,
Wyeth-Ayerst, and ZARS; Speakers Bureau: Abbott
Laboratories, AstraZeneca, Boehringer Ingelheim, Boots
Pharmaceuticals, Bristol-Myers Squibb, Burroughs Wellcome,
Charter Hospitals, Ciba Geigy, Dista Products Company, Eli
Lilly, Excerpta Medica Asia, Glaxo Pharmaceuticals, GlaxoSmithKline, Hospital Corporation of America, Humana, ICI,
Janssen Pharmaceutica, Kali-Duphar, Marion Merrill Dow,
McNeil Pharmaceuticals, Mead Johnson, Merck Sharp &
Dohme, Novo Nordisk, Organon, Parke-Davis, Pfizer, Pharmacia
& Upjohn, Rhone Laboratories, Rhone-Poulenc Rorer
Pharmaceuticals, Roerig, Sandoz Pharmaceuticals, Sanofi-Aventis, Schering Corporation, SmithKlineBeecham, Solvay
Pharmaceuticals, TAP Pharmaceuticals, The Upjohn Company,
Warner Chilcott, and Wyeth-Ayerst; Stock: Medical
Outcome Systems.
George M. Simpson, M.D. Grant Support: AstraZeneca, Janssen,
and Pfizer; Consultant: Janssen, Merck, and Pfizer.
Diane M. Sloan, Pharm.D. Employed by: Advogent (a medical
communications agency that does work with Wyeth Pharmaceuticals).
Zachary N. Stowe, M.D. Grant/Research Support: GlaxoSmithKline, National Institutes of Health, and Wyeth; Advisory
Board: BMS, GlaxoSmithKline, and Wyeth; Speaker's Honoraria:
Eli Lilly, GlaxoSmithKline, Pfizer, and Wyeth.
Pierre N. Tariot, M.D. Grant/Research Support: Abbott Laboratories,
AstraZeneca, Alzheimer's Association, Arizona Department
of Health Services, Bristol-Myers Squibb, Eisai,
Elan, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Institute
for Mental Health Research, Janssen Pharmaceutica,
Merck, Mitsubishi Pharma Corporation, Myriad Pharmaceuticals,
NIA, National Institute of Mental Health, Neurochem,
Ono Pharmaceuticals, Pfizer, Sanofi-Synthelabo, Schwabe,
Takeda Pharmaceuticals North America, and Wyeth Laboratories;
Consultant: Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eisai, Eli Lilly, Forest Laboratories, GlaxoSmithKline, Janssen Pharmaceutica, Memory Pharmaceuticals,
Merck, Myriad Pharmaceuticals, Novartis AG, Pfizer,
Sanofi-Synthelabo, Schwabe, and Takeda Pharmaceuticals
North America; Speakers Bureau: AstraZeneca, Eisai, Forest
Pharmaceuticals, and Pfizer; Educational Fees: AstraZeneca,
Eisai, Forest Laboratories, Lundbeck, and Pfizer; Patents:
Biomarkers of Alzheimer's Disease.
Michael E. Thase, M.D. Consultant/Advisory Board: AstraZeneca,
Bristol-Myers Squibb, Cephalon, Cyberonics, Eli Lilly,
Forest Pharmaceuticals, GlaxoSmithKline, Janssen Pharmaceutica,
MedAvante, Neuronetics, Novartis, Organon, Sepracor,
Shire, Supernus Pharmaceuticals, and Wyeth-Ayerst Laboratories;
Speakers Bureau: AstraZeneca, Bristol-Myers
Squibb, Cyberonics, Eli Lilly, GlaxoSmithKline, Organon,
Sanofi Aventis, and Wyeth-Ayerst Laboratories; Royalty/Patent/Other Income: American Psychiatric Publishing, Guilford
Publications, Herald House, and W.W. Norton; Equity
Holdings: MedAvante; Expert Testimony: Jones Day and Phillips
Lyttle, and Pepper Hamilton.
Gary D. Tollefson, M.D., Ph.D. Employed by: Orexigen Therapeutics.
Karen D. Wagner, M.D., Ph.D. Research Support: National Institute
of Mental Health; Consultant/Advisory Board: Abbott
Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly,
Forest Laboratories, Janssen, Novartis, Otsuka, Pfizer, Sanofi
Aventis, and Solvay.
Margaret B. Weigel, M.D. Grant/Stipend Support: Novartis Pharmaceuticals,
and Ono.
Donna A. Wirshing, M.D. Speakers Bureau: Bristol-Myers
Squibb, and Pfizer.
Frank D. Yocca, Ph.D. Employed by: AstraZeneca Pharmaceuticals
Co.
Kimberly A. Yonkers, M.D. Grant Support: Lilly, National Institute
of Mental Health, Pfizer, and Wyeth.
Jiang-Zhou Yu, M.D., Ph.D. Grant Support: Bristol-Myers
Squibb, and ONO Pharmaceuticals.
The following contributors stated that they had no competing interests
during the year preceding manuscript submission:
W. Stewart Agras, M.D.; Jonathan M. Amiel, M.D.; Josephine
Astrid Archer, B.Sc.; Gregory S. Berns, M.D., Ph.D.; David R.
Block, M.D.; Catherine Bresee, M.S.; Frank W. Brown, M.D.;
Mary F. Brunette, M.D.; Monica Kelly Cowles, M.D., M.S.;
Charles A. Dackis, M.D.; Albert A. Davis, B.S.; Karon Dawkins,
M.D.; Clifford J. Ehmke, M.D.; Dwight L. Evans, M.D.;
Amir Garakani, M.D.; Elizabeth H. Gillespie, D.O.; Robert
N. Golden, M.D.; Todd D. Gould, M.D.; Ebrahim Haroon,
M.D.; Christine Heim, Ph.D.; Jinger G. Hoop, M.D., M.F.A.;
Walter H. Kaye, M.D.; Ashley P. Kennedy, B.S.; Ania Korszun,
Ph.D., M.D., M.R.C.Psych.; Helena C. Kraemer, Ph.D.;
Erin E. Krebs, M.D., M.P.H.; Joseph B. Layde, M.D., J.D.; Thomas
W. Meeks, M.D.; Darlene S. Melchitzky, M.S.; Emmanuel
Mignot, M.D., Ph.D.; Kazuo Mishima, M.D., Ph.D.;
Katherine Marshall Moore, M.D.; Alexander Neumeister,
M.D.; Sandhaya Norris, M.D.; Giuseppe Pagnoni, Ph.D.;
Daniel S. Pine, M.D.; B. Ashok Raj, M.D.; Mark M. Rasenick,
Ph.D.; Martin Reite, M.D.; Laura Weiss Roberts, M.D., M.A.;
J. Amiel Rosenkranz, Ph.D.; Carl Salzman, M.D.; Daphne
Simeon, M.D.; Joseph K. Stanilla, M.D.; Michael Strober,
Ph.D.; Steven T. Szabo, Ph.D.; Rajiv Tandon, M.D.; Anthony
R. West, Ph.D.; Po W. Wang, M.D.; Joanne D. Wojcik,
P.M.H.C.N.S.–B.C.; Tsung-Ung W. Woo, M.D.; Janos Zahajszlay,
M.D.; Charles F. Zorumski, M.D.